IDXX
Price
$452.77
Change
-$0.09 (-0.02%)
Updated
Feb 21 closing price
Capitalization
44.84B
66 days until earnings call
IQV
Price
$191.04
Change
-$2.97 (-1.53%)
Updated
Feb 21 closing price
Capitalization
45.3B
66 days until earnings call
Ad is loading...

IDXX vs IQV

Header iconIDXX vs IQV Comparison
Open Charts IDXX vs IQVBanner chart's image
IDEXX Laboratories
Price$452.77
Change-$0.09 (-0.02%)
Volume$773.21K
Capitalization44.84B
IQVIA Holdings
Price$191.04
Change-$2.97 (-1.53%)
Volume$1.55M
Capitalization45.3B
IDXX vs IQV Comparison Chart
Loading...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDXX vs. IQV commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDXX is a Hold and IQV is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (IDXX: $452.77 vs. IQV: $191.04)
Brand notoriety: IDXX: Not notable vs. IQV: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IDXX: 117% vs. IQV: 113%
Market capitalization -- IDXX: $44.84B vs. IQV: $45.3B
IDXX [@Medical Specialties] is valued at $44.84B. IQV’s [@Medical Specialties] market capitalization is $45.3B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDXX’s FA Score shows that 1 FA rating(s) are green whileIQV’s FA Score has 0 green FA rating(s).

  • IDXX’s FA Score: 1 green, 4 red.
  • IQV’s FA Score: 0 green, 5 red.
According to our system of comparison, IDXX is a better buy in the long-term than IQV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDXX’s TA Score shows that 5 TA indicator(s) are bullish while IQV’s TA Score has 3 bullish TA indicator(s).

  • IDXX’s TA Score: 5 bullish, 5 bearish.
  • IQV’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IDXX is a better buy in the short-term than IQV.

Price Growth

IDXX (@Medical Specialties) experienced а +1.85% price change this week, while IQV (@Medical Specialties) price change was -1.24% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.75%. For the same industry, the average monthly price growth was -1.45%, and the average quarterly price growth was +2.31%.

Reported Earning Dates

IDXX is expected to report earnings on Apr 30, 2025.

IQV is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Medical Specialties (-1.75% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IQV($45.3B) and IDXX($44.8B) have the same market capitalization . IDXX has higher P/E ratio than IQV: IDXX (52.87) vs IQV (34.14). IDXX YTD gains are higher at: 9.513 vs. IQV (-2.784). IQV has higher annual earnings (EBITDA): 3.26B vs. IDXX (1.22B). IQV has more cash in the bank: 1.5B vs. IDXX (454M). IDXX has less debt than IQV: IDXX (1.07B) vs IQV (13.9B). IQV has higher revenues than IDXX: IQV (15B) vs IDXX (3.66B).
IDXXIQVIDXX / IQV
Capitalization44.8B45.3B99%
EBITDA1.22B3.26B37%
Gain YTD9.513-2.784-342%
P/E Ratio52.8734.14155%
Revenue3.66B15B24%
Total Cash454M1.5B30%
Total Debt1.07B13.9B8%
FUNDAMENTALS RATINGS
IDXX vs IQV: Fundamental Ratings
IDXX
IQV
OUTLOOK RATING
1..100
7659
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
5869
SMR RATING
1..100
1842
PRICE GROWTH RATING
1..100
5463
P/E GROWTH RATING
1..100
8281
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IQV's Valuation (71) in the Servicestothe Health Industry industry is in the same range as IDXX (85) in the Medical Specialties industry. This means that IQV’s stock grew similarly to IDXX’s over the last 12 months.

IDXX's Profit vs Risk Rating (58) in the Medical Specialties industry is in the same range as IQV (69) in the Servicestothe Health Industry industry. This means that IDXX’s stock grew similarly to IQV’s over the last 12 months.

IDXX's SMR Rating (18) in the Medical Specialties industry is in the same range as IQV (42) in the Servicestothe Health Industry industry. This means that IDXX’s stock grew similarly to IQV’s over the last 12 months.

IDXX's Price Growth Rating (54) in the Medical Specialties industry is in the same range as IQV (63) in the Servicestothe Health Industry industry. This means that IDXX’s stock grew similarly to IQV’s over the last 12 months.

IQV's P/E Growth Rating (81) in the Servicestothe Health Industry industry is in the same range as IDXX (82) in the Medical Specialties industry. This means that IQV’s stock grew similarly to IDXX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDXXIQV
RSI
ODDS (%)
Bearish Trend 3 days ago
64%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
60%
MACD
ODDS (%)
Bearish Trend 3 days ago
70%
Bearish Trend 3 days ago
59%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
67%
Bearish Trend 3 days ago
62%
Advances
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 18 days ago
62%
Declines
ODDS (%)
Bearish Trend 12 days ago
71%
Bearish Trend 3 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
64%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
58%
View a ticker or compare two or three
Ad is loading...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CELH32.627.09
+27.77%
Celsius Holdings
LBRT17.830.22
+1.25%
Liberty Energy
EML28.19-0.89
-3.06%
Eastern Company
ATHA0.43-0.01
-3.21%
Athira Pharma
TWI8.79-0.43
-4.66%
Titan International

IQV and

Correlation & Price change

A.I.dvisor indicates that over the last year, IQV has been closely correlated with CRL. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
-1.53%
CRL - IQV
69%
Closely correlated
+0.47%
ICLR - IQV
63%
Loosely correlated
-0.22%
MEDP - IQV
56%
Loosely correlated
-1.34%
TMO - IQV
56%
Loosely correlated
-0.98%
BRKR - IQV
55%
Loosely correlated
-3.97%
More